Patent details

EP3658141 Title: TREATING PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPALPHA - CD47 INTERACTION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3658141
WO Application Number:
NL2018050515
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18770099.2
WO Publication Number:
WO2019022600
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Netherlands (NL)
Publications:

Dates

Filing date:
24/07/2018
Grant date:
16/11/2022
EP Publication Date:
03/06/2020
WO Publication Date:
31/01/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
06/02/2023
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
16/11/2022
EP B1 Publication Date:
16/11/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
23/07/2038
Lapsed By Expiration Date:
Patent Validated Date:
08/02/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
19/04/2023
 
 

 

Name:
Scenic Immunology B.V.
Address:
Matrix ONE Science Park 301, 1098 XH, Amsterdam, Netherlands (NL)

Historical Applicant/holder

From:
16/11/2022
To:
19/04/2023

 

Name:
Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis
Address:
Plesmanlaan 121, 1066 CX Amsterdam, Netherlands (NL)

From:
16/11/2022
To:
19/04/2023

 

Name:
Academisch Ziekenhuis Leiden h.o.d.n. LUMC
Address:
Albinusdreef 2, 2333 ZA, LEIDEN, Netherlands (NL)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
07/02/2023
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
RAABEN, Matthijs
Address:
1191 PN Ouderkerk aan de Amstel, Netherlands (NL)

2

Name:
SCHEEREN, Ferenc Alexander
Address:
NL-2333 ZA Leiden, Netherlands (NL)

3

Name:
LOGTENBERG, Meike Emma Willemijn
Address:
1066 CX Amsterdam, Netherlands (NL)

4

Name:
BRUMMELKAMP, Thijn Reinout
Address:
1066 CX Amsterdam, Netherlands (NL)

5

Name:
SCHUMACHER, Antonius Nicolaas Maria
Address:
1066 CX Amsterdam, Netherlands (NL)

6

Name:
LEUSEN, Jeannette Henrica Wilhelmina
Address:
3515 VV Utrecht, Netherlands (NL)

Priority

1

Priority Patent Number:
2020938
Priority Date:
15/05/2018
Priority Country:
Netherlands (NL)

2

Priority Patent Number:
2019333
Priority Date:
24/07/2017
Priority Country:
Netherlands (NL)

Classification

IPC or IDT classification:
A61K 31/417; A61K 39/00; A61K 45/00; A61P 31/00; A61P 9/10; A61P 25/28;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
18/23
Publication date:
03/05/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
06/23
Publication date:
08/02/2023
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
46/22
Publication date:
16/11/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202246
Publication date:
16/11/2022
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202300814A
Date Registered:
19/04/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Scenic Immunology B.V.
Address:
Matrix ONE Science Park 301, 1098 XH, Amsterdam, Netherlands (NL)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2025
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
10/06/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Patentrenewal.com ApS
Filing date Document type Document Description Number of pages File Type
07/02/2023 Outgoing Correspondence Letter no formal defects 1 PDF /5/1/6/6/3/0800836615/docs/ep18770099.2_0_529905l271.pdf
06/02/2023 Claims First filed claims 18 PDF /5/1/6/6/3/0800836615/docs/ep18770099.2_1_claims20230206114521220.pdf